Top Markets
Coin of the day
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
Rank in Stocks #26781
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
Share Price
$0.52468396
Market Cap
$37.85M
Change (1 day)
1.23%
Change (1 year)
-4.53%
Country
TW
Trade Enimmune corporation (6564)

Category

Stock price history for Enimmune corporation (6564)
Highest end of day price: $0.53 on 2026-08-01

Lowest end of day price: $0.89 on 2018-09-01
Stock price history of Enimmune corporation from 2018 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -7.73%
2025 -21.37%
2024 -30.67%
2023 -42.89%
2022 47.58%
2021 -3.50%
2020 86.97%
2019 -4.98%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$543.36 37.78%
US
$1.03K 55.65%
NL
$120.74 -14.98%
AU
$139.64 419.30%
US
$762.65 7.15%
CH